Morgan Stanley’s GMO US Quality ETF QLTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.3M Buy
462,955
+451,869
+4,076% +$18.1M ﹤0.01% 3133
2026
Q1
$401K Buy
11,086
+3,964
+56% +$152K ﹤0.01% 5584
2025
Q4
$274K Buy
7,122
+1
+0% +$38 ﹤0.01% 5796
2025
Q3
$258K Hold
7,121
﹤0.01% 5789
2025
Q2
$244K Buy
7,121
+7,120
+712,000% +$226K ﹤0.01% 5775
2025
Q1
$52 Sell
1
-1
-50% -$33 ﹤0.01% 7709
2024
Q4
$89 Buy
2
+1
+100% +$33 ﹤0.01% 7484
2024
Q3
$45 Buy
+1
New +$31 ﹤0.01% 7609

Other funds holding QLTY

Morgan Stanley's QLTY Position: Q2 2026 in Review

Morgan Stanley increased its GMO US Quality ETF (QLTY) stake by 4,076% in Q2 2026, buying an estimated $18.1M and bringing the position to 462,955 shares worth $19.3M. The position accounts for ﹤0.01% of the portfolio, ranked #3133.

Morgan Stanley first reported a position in QLTY in Q3 2024 and has held it in 8 quarters since. 160 funds tracked by Wall St. Rank hold QLTY as of Q2 2026.

  • Morgan Stanley held 462,955 shares of GMO US Quality ETF worth $19.3M as of Q2 2026.
  • Morgan Stanley bought 451,869 GMO US Quality ETF shares in Q2 2026, an estimated $18.1M.
  • GMO US Quality ETF made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #3133 holding.
  • Morgan Stanley first reported a position in GMO US Quality ETF in Q3 2024 and has held it in 8 quarters since.
  • 160 funds tracked by Wall St. Rank held GMO US Quality ETF as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.